Safety of oral terbinafine for toenail onychomycosis.

  title={Safety of oral terbinafine for toenail onychomycosis.},
  author={Richard Pollak and Stephan Billstein},
  journal={Journal of the American Podiatric Medical Association},
  volume={87 12},
This open-label multicenter study evaluated the safety and efficacy of 12, 18, and 24 weeks of daily treatment with a 250-mg tablet of terbinafine for onychomycosis of the toenails. The safety data for 1,508 patients with a mean age of 50 years are reported here. Percentages below are based on this denominator. All patients received at least 12 weeks of therapy, with a possible addition of 6 or 12 weeks depending on disease extent. Patients were evaluated at baseline and at weeks 6, 12, 24, 30… CONTINUE READING

From This Paper

Topics from this paper.


Publications citing this paper.

Similar Papers

Loading similar papers…